Document Detail


The efficacy of Ajmaline in ventricular arrhythmias after failure of lidocaine therapy in the acute phase of myocardial infarction.
MedLine Citation:
PMID:  6187246     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Forty-three patients in the acute phase of myocardial infarction who were resistant to conventional doses of lidocaine received Ajmaline intravenously (50 mg bolus followed by constant infusion rate of 1-1.5 mg/min). Dangerous ventricular arrhythmias were abolished in 72% of this group of patients (group A). In the remaining patients (28%), Ajmaline was found to be ineffective (group B). There was no reduction of systolic or diastolic blood pressure and there was an insignificant increase in heart rate. Atrio-ventricular or intraventricular conduction defects appeared in 46% of the patients described. There was a statistically significant increase in occurrence of heart blocks in group B patients and among these complete left bundle branch block (CLBBB) was the most prevalent. Atrio-ventricular or intraventricular conduction defects were transient, appearing between 8-36 h (mean 23 h), and were not accompanied by reduction of ventricular rate. Conduction defects disappeared within several hours (up to 24 hours) after Ajmaline was discontinued. It is concluded that Ajmaline administered by this regimen is an effective alternative agent for patients with ventricular arrhythmia not controlled by lidocaine in the acute phase of myocardial infarction.
Authors:
E Grenadier; G Alpan; S Keidar; D Weiss; A Marmor; A Palant
Related Documents :
15904926 - A histological study of the cardiac conduction system in a heifer with complete atriove...
6182116 - Electrocardiographic ischemic st-t changes and ventricular premature systoles.
4009956 - An adult case of arrhythmogenic right ventricular dysplasia.
7226596 - Clinical evaluation of his-bundle electrogram recorded from the body surface.
17867926 - Catheter ablation for ventricular tachycardia: indications and techniques.
21980376 - Miquant--semi-automation of infarct size assessment in models of cardiac ischemic injury.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Angiology     Volume:  34     ISSN:  0003-3197     ISO Abbreviation:  Angiology     Publication Date:  1983 Mar 
Date Detail:
Created Date:  1983-04-15     Completed Date:  1983-04-15     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0203706     Medline TA:  Angiology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  204-14     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Ajmaline / therapeutic use*
Cardiac Complexes, Premature / physiopathology
Digoxin / therapeutic use
Heart Conduction System / physiopathology
Heart Failure / drug therapy
Humans
Lidocaine / therapeutic use*
Myocardial Infarction / drug therapy,  physiopathology*
Time Factors
Ventricular Fibrillation / drug therapy*
Chemical
Reg. No./Substance:
137-58-6/Lidocaine; 20830-75-5/Digoxin; 4360-12-7/Ajmaline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Morphological differentiation of human spermatozoa using pre-prepared methods. Comparative studies
Next Document:  Staphylococcal protein A and enhancement of disc RAST sensitivity.